(GLAD) Gladstone Capital - Overview
Stock: Debt, Equity, Mezzanine
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.49% |
| Yield on Cost 5y | 17.97% |
| Yield CAGR 5y | 27.09% |
| Payout Consistency | 94.2% |
| Payout Ratio | 39.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.2% |
| Relative Tail Risk | 4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.25 |
| Alpha | -41.72 |
| Character TTM | |
|---|---|
| Beta | 0.744 |
| Beta Downside | 0.901 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.56% |
| CAGR/Max DD | 0.18 |
Description: GLAD Gladstone Capital December 26, 2025
Gladstone Capital Corporation (NASDAQ:GLAD) is a Business Development Company (BDC) that focuses on providing growth-capital and credit solutions to lower-middle-market U.S. companies, typically with $20 M–$150 M in revenue and $3 M–$25 M EBITDA.
The firm deploys a broad suite of financing structures-including senior term loans, unitranche, mezzanine, and equity-linked instruments-ranging from $8 M to $40 M per transaction, and it often takes minority equity positions to support add-on acquisitions and “buy-and-build” strategies.
Gladstone’s target industries are sector-agnostic but concentrate on business services, light and specialty manufacturing, niche industrial products, specialty consumer goods, energy services, transportation & logistics, healthcare & education, specialty chemicals, media & communications, and aerospace & defense.
From a market perspective, GLAD’s dividend yield (≈ 7.5% as of Q3 2025) and its net asset value (≈ $1.1 B) make it a relatively high-yielding BDC, while the firm’s performance is sensitive to credit-spread dynamics and the overall health of the U.S. lower-middle-market M&A environment.
Key economic drivers include the Federal Reserve’s policy stance-higher rates can compress loan pricing but also increase demand for refinancing-and the ongoing consolidation trend in fragmented industrial and service sectors, which fuels “buy-and-build” opportunities.
For a deeper quantitative view, you may want to explore GLAD’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 58.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.91 > 1.0 |
| NWC/Revenue: 49.64% < 20% (prev 5.61%; Δ 44.03% < -1%) |
| CFO/TA -0.02 > 3% & CFO -13.8m > Net Income 58.1m |
| Net Debt (365.5m) to EBITDA (58.1m): 6.29 < 3 |
| Current Ratio: 9.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.8m) vs 12m ago 9.23% < -2% |
| Gross Margin: 74.25% > 18% (prev 0.82%; Δ 7344 % > 0.5%) |
| Asset Turnover: 9.03% > 50% (prev 14.80%; Δ -5.78% > 0%) |
| Interest Coverage Ratio: 2.91 > 6 (EBITDA TTM 58.1m / Interest Expense TTM 20.0m) |
Altman Z'' 0.76
| A: 0.04 (Total Current Assets 42.9m - Total Current Liabilities 4.33m) / Total Assets 907.6m |
| B: 0.01 (Retained Earnings 5.20m / Total Assets 907.6m) |
| C: 0.07 (EBIT TTM 58.1m / Avg Total Assets 860.0m) |
| D: 0.01 (Book Value of Equity 5.24m / Total Liabilities 425.6m) |
| Altman-Z'' Score: 0.76 = B |
What is the price of GLAD shares?
Over the past week, the price has changed by -7.71%, over one month by -8.47%, over three months by +1.66% and over the past year by -28.19%.
Is GLAD a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GLAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.5 | 18.3% |
| Analysts Target Price | 22.5 | 18.3% |
| ValueRay Target Price | 21.9 | 15.4% |
GLAD Fundamental Data Overview February 02, 2026
P/E Forward = 11.1235
P/S = 5.2248
P/B = 0.9693
P/EG = 2.3116
Revenue TTM = 77.6m USD
EBIT TTM = 58.1m USD
EBITDA TTM = 58.1m USD
Long Term Debt = unknown (none)
Short Term Debt = 397.9m USD (from shortTermDebt, last fiscal year)
Debt = 397.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 365.5m USD (from netDebt column, last quarter)
Enterprise Value = 831.1m USD (465.6m + Debt 397.9m - CCE 32.4m)
Interest Coverage Ratio = 2.91 (Ebit TTM 58.1m / Interest Expense TTM 20.0m)
EV/FCF = -60.44x (Enterprise Value 831.1m / FCF TTM -13.8m)
FCF Yield = -1.65% (FCF TTM -13.8m / Enterprise Value 831.1m)
FCF Margin = -17.71% (FCF TTM -13.8m / Revenue TTM 77.6m)
Net Margin = 74.86% (Net Income TTM 58.1m / Revenue TTM 77.6m)
Gross Margin = 74.25% ((Revenue TTM 77.6m - Cost of Revenue TTM 20.0m) / Revenue TTM)
Gross Margin QoQ = 71.74% (prev 63.25%)
Tobins Q-Ratio = 0.92 (Enterprise Value 831.1m / Total Assets 907.6m)
Interest Expense / Debt = 1.45% (Interest Expense 5.77m / Debt 397.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.9m (EBIT 58.1m * (1 - 21.00%))
Current Ratio = 9.90 (Total Current Assets 42.9m / Total Current Liabilities 4.33m)
Debt / Equity = 0.83 (Debt 397.9m / totalStockholderEquity, last quarter 482.0m)
Debt / EBITDA = 6.29 (Net Debt 365.5m / EBITDA 58.1m)
Debt / FCF = -26.58 (negative FCF - burning cash) (Net Debt 365.5m / FCF TTM -13.8m)
Total Stockholder Equity = 487.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.76% (Net Income 58.1m / Total Assets 907.6m)
RoE = 11.91% (Net Income TTM 58.1m / Total Stockholder Equity 487.8m)
RoCE = 6.43% (EBIT 58.1m / Capital Employed (Total Assets 907.6m - Current Liab 4.33m))
RoIC = 5.76% (NOPAT 45.9m / Invested Capital 797.6m)
WACC = 5.20% (E(465.6m)/V(863.5m) * Re(8.66%) + D(397.9m)/V(863.5m) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.55%
Fair Price DCF = unknown (Cash Flow -13.8m)
EPS Correlation: 87.59 | EPS CAGR: 19.10% | SUE: 0.69 | # QB: 0
Revenue Correlation: 42.04 | Revenue CAGR: 9.57% | SUE: 3.11 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.48 | Chg30d=+0.001 | Revisions Net=-1 | Analysts=6
EPS current Year (2026-09-30): EPS=1.92 | Chg30d=+0.010 | Revisions Net=-4 | Growth EPS=-4.8% | Growth Revenue=+12.6%
EPS next Year (2027-09-30): EPS=1.87 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=-2.8% | Growth Revenue=+6.6%